About Gladius Therapeutics
Gladius Therapeutics is a private company based in Philadelphia, Pennsylvania, incorporated in 2023 in Delaware. It has reported $300,000 raised in one offering on Form D since August 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2023 | Aug 22, 2023 | $300,000fully sold | 4 | $75,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gladius Therapeutics's Form D filed Aug 22, 2023.
MS
Michael Seiden
President and director